Insider Transactions

What ALEXION PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Coughlin Christopher J	Director	Jul 21	Disposition to Issuer · D	−42,347	—	—	0
Franchini Indrani Lall	EVP, Chief Compliance Officer	Jul 21	Disposition to Issuer · D	−116,075	—	—	0
Goff Brian	EVP & Chief Commercial Officer	Jul 21	Disposition to Issuer · D	−150,832	—	—	0
Hantson Ludwig	CEO	Jul 21	Disposition to Issuer · D	−580,809	—	—	9,098
Friedman Paul A	Director	Jul 21	Disposition to Issuer · D	−12,840	—	—	0
Brennan David R	Director	Jul 21	Disposition to Issuer · D	−20,873	—	—	0
Dunsire Deborah	Director	Jul 21	Disposition to Issuer · D	−14,629	—	—	0
Nader Francois	Director	Jul 21	Disposition to Issuer · D	−13,921	—	—	0
Reinsdorf Judith A	Director	Jul 21	Disposition to Issuer · D	−14,150	—	—	0
Orloff John J	EVP, Research & Development	Jul 21	Disposition to Issuer · D	−146,511	—	—	0
Rummelt Andreas	Director	Jul 21	Disposition to Issuer · D	−28,109	—	—	0
Bazarko Daniel	SVP, Controller, CAO	Jul 21	Disposition to Issuer · D	−60,207	—	—	0
Chiniara Ellen	EVP & Chief Legal Officer	Jul 21	Disposition to Issuer · D	−116,850	—	—	0
Mollen John T	Director	Jul 21	Disposition to Issuer · D	−15,336	—	—	0
Carino Tanisha	EVP & CCAO	Jul 21	Disposition to Issuer · D	−59,226	—	—	0
Sarin Aradhana	EVP, CFO	Jul 21	Disposition to Issuer · D	−120,253	—	—	0
Goff Brian	EVP & Chief Commercial Officer	Jul 14	Grant / award · A	+29,501	—	—	150,832
Goff Brian	EVP & Chief Commercial Officer	Jul 14	Grant / award · A	+30,643	—	—	121,331
Orloff John J	EVP, Research & Development	Jul 14	Grant / award · A	+29,501	—	—	146,511
Orloff John J	EVP, Research & Development	Jul 14	Grant / award · A	+30,643	—	—	117,010

Page 1 of 134 · showing the 20 most recent Sign up free to view all 2,666 transactions and filter by insider →

Comments